comparemela.com
Home
Live Updates
Numab Therapeutics AG: Numab and 3SBios Sunshine Guojian Expand Partnership to Develop Novel T Cell Engager NM28 : comparemela.com
Numab Therapeutics AG: Numab and 3SBio's Sunshine Guojian Expand Partnership to Develop Novel T Cell Engager NM28
Numab Therapeutics AG (Numab) and 3SBio Inc. ("3SBio", HKEX:1530) announced today that 3SBio's subsidiary Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. ("Sunshine Guojian") exercised its option
Related Keywords
Taiwan ,
Shanghai ,
China ,
Hong Kong ,
Shenzhen ,
Guangdong ,
Shenyang ,
Liaoning ,
Italy ,
Zurich ,
Züsz ,
Switzerland ,
Guojian ,
Jing Lou ,
Hangzhou ,
Zhejiang ,
Macao ,
Macau General ,
Macau ,
David Urech ,
Madeline Davidshofer ,
Sunshine Guojian Pharmaceutical Shanghai Co Ltd ,
3sbio Inc ,
,
Numab Therapeutics ,
Sunshine Guojian Pharmaceutical ,
Sunshine Guojian ,
Greater China ,
Chief Executive Officer ,
Serum Albumin ,
Executive Officer ,
Dougall Advisors ,
Numab ,
Herapeutics ,
Lsbio ,
Sunshine ,
Xpand ,
Partnership ,
Evelop ,
Novel ,
Fell ,
Engager ,
M28 ,
comparemela.com © 2020. All Rights Reserved.